Wallerich Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 4 Days
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 33.39%
- Profit Growth 78.23%
- Ebitda -226.96%
- Net Worth -0.58%
- Total Assets 17.76%
About Wallerich Life Sciences
Wallerich Life Sciences Private Limited (WLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 January 2015 and has a history of Ten years. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jijith Viswam and Sarin Sha serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100KA2015PTC078562
-
Company No.
078562
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Jan 2015
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Wallerich Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jijith Viswam
|
Managing Director | 28-Jan-2015 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sarin Sha
|
Director | 28-Jan-2015 | Current |
Financial Performance of Wallerich Life Sciences.
Wallerich Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.39% increase. The company also saw a substantial improvement in profitability, with a 78.23% increase in profit. The company's net worth dipped by a decrease of 0.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wallerich Life Sciences?
Unlock access to Wallerich Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Wallerich Health Care LlpJijith Viswam and Sarin Sha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wallerich Life Sciences?
Unlock and access historical data on people associated with Wallerich Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wallerich Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wallerich Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
